CNTB
Connect Biopharma Holdings
$2.10
−$0.04 (−1.87%)Jul 27, 2026
Key metrics
The numbers that frame CNTB today
- Market cap
- $132.22M
- P/E (TTM)
- -2.0
- EV / FCF
- -1.5
- Gross margin
- 100%
- EV / Sales
- 372.9
- ROIC
- -482.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.23
- 52wk High
- $3.82
Growth
Revenue and earnings trend for CNTB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CNTB
Is Connect Biopharma Holdings a good buy?
No. Connect Biopharma Holdings has poor quality and weak momentum. Both signals point to a weaker setup. We think Connect Biopharma Holdings is selling at a very high price.
What is the market capitalization of CNTB?
Connect Biopharma Holdings's market capitalization is $132.22M.
What is the P/E ratio for CNTB stock?
Connect Biopharma Holdings's current P/E ratio is -2.
What is the 52-week high for CNTB stock?
The 52-week high for Connect Biopharma Holdings is $3.82. The current close of $2.10 is 45% below that high.
What is the 52-week low for CNTB stock?
The 52-week low for Connect Biopharma Holdings is $1.23. The current close of $2.10 is 70.7% above that low.
Does CNTB stock pay dividends?
Connect Biopharma Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CNTB?
Connect Biopharma Holdings's Debt / Equity ratio is 0.02.